Does Finasteride Cause Hair Growth in Men with Androgenetic Alopecia?
Yes, finasteride 1 mg daily promotes hair regrowth in men with androgenetic alopecia by increasing hair count, hair weight, and converting hairs from telogen to anagen phase, with effects sustained over 5 years of treatment.
Mechanism and Evidence of Efficacy
Finasteride works by competitively inhibiting Type II 5α-reductase, reducing scalp dihydrotestosterone (DHT) by approximately 70%, which is the primary androgen responsible for follicular miniaturization in male pattern hair loss 1. This isn't just preventing further loss—it actively promotes regrowth.
Quantifiable Hair Growth Outcomes
The evidence for finasteride's hair-promoting effects in men is robust:
Hair count improvements: In the 1-inch diameter target area (5.1 cm²), finasteride produced a net increase of 107 hairs at 1 year and 138 hairs at 2 years compared to progressive loss with placebo 2
Anagen conversion: Finasteride increased anagen (growth phase) hair count by 26% at 48 weeks, with a 47% improvement in the anagen-to-telogen ratio, directly demonstrating conversion of resting hairs into actively growing hairs 3
Hair weight increases: Beyond just numbers, finasteride increased hair weight by 25.6% at 48 weeks and 35.8% at 96 weeks—substantially greater than the hair count increase, indicating that individual hairs become thicker and longer, not just more numerous 4
Long-term durability: Five-year data confirms sustained improvements with continued treatment, while placebo-treated men experienced progressive hair loss 5
Clinical Application in Men
For men aged 18-41 with androgenetic alopecia, prescribe finasteride 1 mg orally once daily. The standard 1 mg dose used for male pattern baldness is well-established and FDA-approved 1.
Timeline and Expectations
- Initial shedding may occur at 2-8 weeks (telogen hairs shedding to make way for anagen growth)
- Visible improvements typically begin at 3-4 months
- Maximal effect achieved at 12-24 months
- Continued treatment necessary to maintain benefits—discontinuation returns DHT levels to baseline within 2 weeks 1
Safety Profile in Men
The medication is generally well-tolerated in men. Sexual side effects (erectile dysfunction, decreased libido) are the most commonly reported adverse events, though serious events are rare 6, 2, 5. The 1 mg dose has an established safety profile over 5 years of continuous use 5.
Important Caveat: Limited Efficacy in Women
The evidence presented is specific to men. The guidelines explicitly note that in women with female pattern hair loss (FPHL), 1 mg daily finasteride was no more effective than placebo in postmenopausal women 7. Higher doses (2.5-5 mg daily) showed some benefit in postmenopausal women, but the data for women is far less robust than for men 7.
Women of childbearing potential should avoid finasteride entirely due to teratogenic risk (feminization of male fetuses), requiring strict contraception during treatment and for at least 30 days after discontinuation 7.
Comparison to Alternatives
Recent evidence suggests dutasteride (0.5 mg daily) may be more effective than finasteride in men, particularly for central and vertex areas, though it has a longer half-life requiring 6 months post-discontinuation before pregnancy attempts 7, 6. Both medications showed similar hair density improvements with comparable safety profiles in head-to-head comparison 6.
Finasteride remains first-line systemic therapy for male androgenetic alopecia, often combined with topical minoxidil for enhanced results 7, 8, 9.